Phenotyping hepatitis B virus variants: From transfection towards a small animal in vivo infection model

Journal of Clinical Virology

Volumn 34, Issue SUPPL. 1, 2005, Pages

  Nassal, Michael ^a   Dallmeier, Kai ^a   Schultz, Ursula ^a   Sun, Dianxing ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Adefovir; Drug resistant HBV variants; Hepadnavirus host range; Lamivudine; Vaccine escape HBV variants

Indexed keywords

VIRUS DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOLOGICAL MODEL; DNA TRANSFECTION; GENE MUTATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IN VIVO STUDY; LIVER CELL CULTURE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIRION; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS REPLICATION;

ANIMALS; DISEASE MODELS, ANIMAL; HEPADNAVIRIDAE; HEPATITIS B; HEPATITIS B VIRUS; PHENOTYPE; TRANSFECTION; VARIATION (GENETICS); VIRUS REPLICATION;

EID: 32044469436     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(05)80017-4     Document Type: Article

References (29)

1. Baron U., and Bujard H. Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances Methods Enzymol 327 2000 401 421
2. Basuni A.A., and Carman W.F. HBV vaccine-escape variants Methods Mol Med 95 2004 115 124
3. Dandri M., Burda M.R., Torok E., Pollok J.M., Iwanska A., and Sommer G. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus Hepatology 33 2001 981 988
4. Dandri M., Burda M.R., Zuckerman D.M., Wursthorn K., Matschl U., and Pollok J.M. Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes J Hepatol 42 2005 54 60
5. Deres K., Schröder C.H., Paessens A., Goldmann S., Hacker H.J., and Weber O. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids Science 299 2003 893 896
6. Durantel D., Carrouee-Durantel S., Werle-Lapostolle B., Brunelle M.N., Pichoud C., and Trepo C. A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus Hepatology 40 2004 855 864
7. Fu L., and Cheng Y.C. Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus Antimicrob Agents Chemother 44 2000 3402 3407
8. Glebe D., Aliakbari M., Krass P., Knoop E.V., Valerius K.P., and Gerlich W.H. Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus J Virol 77 2003 9511 9521
9. Glebe D., Berting A., Broehl S., Naumann H., Schuster R., and Fiedler N. Optimised conditions for the production of hepatitis B virus from cell culture Intervirology 44 2001 370 378
10. Gripon P., Rumin S., Urban S., Le Seyec J., Glaise D., and Cannie I. Infection of a human hepatoma cell line by hepatitis B virus Proc Natl Acad Sci USA 99 2002 15655 15660
11. Ishikawa T., and Ganem D. The pre-S domain of the large viral envelope protein determines host range in avian hepatitis B viruses Proc Natl Acad Sci USA 92 1995 6259 6263
12. Köck J., Nassal M., MacNelly S., Baumert T.F., Blum H.E., and von Weizsäcker F. Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus J Virol 75 2001 5084 5089
13. Kuhnel F., Fritsch C., Krause S., Mundt B., Wirth T., and Paul Y. Doxycycline regulation in a single retroviral vector by an autoregulatory loop facilitates controlled gene expression in liver cells Nucleic Acids Res 32 2004 c30
14. Ladner S.K., Miller T.J., Otto M.J., and King R.W. The hepatitis B virus M539V polymerase variation responsible for 3TC resistance also confers cross-resistance to other nucleoside analogues Antivir Chem Chemother 9 1998 65 72
15. Ladner S.K., Otto M.J., Barker C.S., Zaifert K., Wang G.H., and Guo J.T. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication Antimicrob Agents Chemother 41 1997 1715 1720
16. Lau D.T., Khokhar M.F., Doo E., Ghany M.G., Herion D., and Park Y. Long-term therapy of chronic hepatitis B with lamivudine Hepatology 32 2000 828 834
17. Nassal M. Hepatitis B virus replication: novel roles for virus host interactions Intervirology 42 1999 100 116
18. Nassal M. Macromolecular interactions in hepatitis B virus replication and particle assembly Cann A.J. DNA Virus Replication. Volume 26 of Frontiers in Molecular Biology 2000 Oxford University Press Warszawa 1 40
19. Prassolov A., Hohenberg H., Kalinina T., Schneider C., Cova L., and Krone O. New hepatitis B virus of cranes that has an unexpected broad host range J Virol 77 2003 1964 1976
20. Pugh J.C., and Simmons H. Duck hepatitis B virus infection of Muscovy duck hepatocytes and nature of virus resistance in vivo J Virol 68 1994 2487 2494
21. Ren S., and Nassal M. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors J Virol 75 2001 1104 1116
22. Schultz U., Grgacic E., and Nassal M. Duck hepatitis B virus: an invaluable model system for HBV infection Adv Virus Res 63 2004 1 70
23. Seeger C., Baldwin B., Hornbuckle W.E., Yeager A.E., Tennant B.C., and Cote P. Woodchuck hepatitis virus is a more efficient oncogenic agent than ground squirrel hepatitis virus in a common host J Virol 65 1991 1673 1679
24. Sells M.A., Chen M.L., and Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA Proc Natl Acad Sci USA 84 1987 1005 1009
25. Sprinzl M.F., Oberwinkler H., Schaller H., and Protzer U. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier J Virol 75 2001 5108 5118
26. Urban S., and Gripon P. Inhibition of duck hepatitis B virus infection by a myristoylated pre-S peptide of the large viral surface protein J Virol 76 2002 1986 1990
27. Villeneuve J.P., Durantel D., Durantel S., Westland C., Xiong S., Brosgart C.L., Gibbs C.S., Parvaz P., Werle B., Trepo C., and Zoulim F. Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient J Hepatol 39 2003 1085 1089
28. von Weizsäcker F., Köck J., MacNelly S., Ren S., Blum H.E., and Nassal M. The tupaia model for the study of hepatitis B virus: direct infection and HBV genome transduction of primary tupaia hepatocytes Methods Mol Med 96 2004 153 161
29. Walters K.A., Tipples G.A., Allen M.I., Condreay L.D., Addison W.R., and Tyrrell L. Generation of stable cell lines expressing lamivudine-resistant hepatitis B virus for antiviral-compound screening Antimicrob Agents Chemother 47 2003 1936 1942